Related references
Note: Only part of the references are listed.Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
Hui Yin Lim et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
Shehan N. Randeria et al.
CARDIOVASCULAR DIABETOLOGY (2019)
A review of global coagulation assays - Is there a role in thrombosis risk prediction?
Hui Yin Lim et al.
THROMBOSIS RESEARCH (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Coagulatory Defects in Type-1 and Type-2 Diabetes
Amelie I. S. Sobczak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
Alicia Jenkins et al.
CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM (2019)
Significant age, race and gender differences in global coagulation assays parameters in the normal population
Prahlad Ho et al.
THROMBOSIS RESEARCH (2017)
A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis
Marcus D. Lance
THROMBOSIS JOURNAL (2015)
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
Richard J. MacIsaac et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Inverse association of the endogenous thrombin potential (ETP) with cardiovascular death: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Jochen G. Schneider et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications
Hyun Kyung Kim et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis
Malgorzata Konieczynska et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Cardiovascular Risks in Prediabetes: Preliminary Data on Vasculopathy Triad
Ezekiel U. Nwose et al.
NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES (2014)
Vascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Christian Rask-Madsen et al.
CELL METABOLISM (2013)
HbA(1c) for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
Bernd Kowall et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2013)
Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation - The Hoorn Study
Hanneke J. B. H. Beijers et al.
THROMBOSIS RESEARCH (2012)
Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay
Armando Tripodi et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)
Coagulation and fibrinolysis in diabetes
S. H. Alzahrani et al.
DIABETES & VASCULAR DISEASE RESEARCH (2010)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Peripheral arterial disease and Virchow's triad
Philip C. Bennett et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram
Kellie R. Machlus et al.
THROMBOSIS AND HAEMOSTASIS (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Diabetes mellitus as a prothrombotic condition
P. J. Grant
JOURNAL OF INTERNAL MEDICINE (2007)
Thrombin generation and fibrin clot structure
Alisa S. Wolberg
BLOOD REVIEWS (2007)
Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
JP Antovic et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Diabetes-related morbidity and mortality in a national sample of US elders
AG Bertoni et al.
DIABETES CARE (2002)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
A simple and rapid laboratory method for determination of haemostasis potential in plasma II.: Modifications for use in routine laboratories and research work
S He et al.
THROMBOSIS RESEARCH (2001)
Diabetes mellitus - A hypercoagulable state
ME Carr
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2001)
Share Paper
